7|10000|Public
50|$|Tables V and VI {{comprise}} precursor substances (<b>and</b> <b>salts</b> <b>thereof)</b> {{which may}} be used to manufacture drugs listed under Tables I and II.|$|E
40|$|A {{compound}} of formula (I) <b>and</b> <b>salts</b> <b>thereof</b> are provided wherein Y {{is defined in}} the specification. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example {{in the treatment of}} a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed...|$|E
40|$|Compound of formula (I) <b>and</b> <b>salts</b> <b>thereof</b> are provided: wherein A, R 1, R, R 2 are {{as defined}} in the specification. Processes for preparation, {{pharmaceutical}} compositions, and uses thereof as a medicament, for example {{in the treatment of}} a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed...|$|E
5000|$|Zipeprol(4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Fenproporex (d,l-3-(α-methylphenethyl)aminopropionitrile) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
40|$|The {{invention}} provides {{compounds of formula}} (I) <b>and</b> <b>salts</b> <b>thereof</b> wherein R 1, R 2, R 3, R 4 and X are {{as defined}} in the description. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example {{in the treatment of}} a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed...|$|E
40|$|Compounds of formula (I) <b>and</b> <b>salts</b> <b>thereof</b> are provided: wherein n is 0, 1, 2 or 3; R 1 is {{selected}} from phenyl and pyridyl, {{each of which}} is optionally substituted by one or two groups independently selected from C 1 - 4 alkyl and halogen; and R 2 {{is selected}} from H and CH 3 when n is 1 and R 2 is H when n is 2 or 3. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed...|$|E
40|$|New piperidinyl-alkyl-benzamides <b>and</b> <b>salts</b> <b>thereof</b> are disclosed, {{together}} with a method {{for the production of}} the benzamides and salts. The benzamides, which have beta-adrenergic agonist effects, have the general formula ##STR 1 ## The hydrochlorides which exemplify the salts, have the general formula ##STR 2 ## In the foregoing formulas R is hydrogen, an alkyl group having from 1 to 4 carbon atoms, an alkoxy group having from 1 to 4 carbon atoms, halo, amino, hydroxy or trifluoromethyl, n is 1, 2 or 3 when R is methoxy but is otherwise 1, and x is 1, 2 or 3. The hydrochloride salts of the benzamides according to the invention can be produced by the reactions illustrated below: ##STR 3 ## Wherein R, n and x have the meanings set forth above and Y can be [...] Cl, [...] F, or [...] OCH 3...|$|E
5000|$|Diethylpropion (2-(diethylamino)propiophenone) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Butorphanol (l-N-cyclobutylmethyl-3,14-dihydroxymorphinan) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Benzylcyclidine (1-1-(Phenylmethyl)cyclohexylpiperidine) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
40|$|The present {{invention}} {{relates to}} the use of a compound of the following formula (I) for detecting a peptidase activity and/or a variation in pH: according to which: Y 1 is a peptide, H or an alkyl W 1, W 2, W 3 and W 4 are independently H, Br, Cl, F, I, alkyl, alkoxy, thiomethyl, perfluoroalkyl, nitro, cyano, carboxyl (including the esters or amides thereof) or any combination thereof n = 0, 1 or 2 X is NR, CZ 5 Z 6, S or O, R being H, alkyl, aralkyl, aryl, alkanoic or alkylsulphonic, Z 5 and Z 6 being an alkyl Y is N or N+R, R being alkyl, aralkyl, aryl, alkanoic or alkylsulphonic Z 1, Z 2, Z 3 and Z 4 being independently H, Br, Cl, F, I, alkyl, aryl, alkoxy, perfluoroalkyl, nitro, cyano, carboxyl, sulphonyl, including the carboxyl or sulphonyl esters or amides <b>and</b> <b>salts</b> <b>thereof...</b>|$|E
5000|$|Chlorphentermine (1-(p-chlorophenyl)-2-methyl-2-aminopropane) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Clotiazepam (5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno2,3-e-1,4-diazepin-2-one) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Clozapine (8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzob,e1,4diazepine) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Harmaline (4,9-dihydro-7-methoxy-1-methyl-3H-pyrido(3,4-b)indole) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Harmalol (4,9-dihydro-1-methyl-3H-pyrido(3,4-b)indol-7-ol) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Mefenorex (d,l-N-(3-chloropropyl)-α-methylbenzeneethanamine) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Methaqualone (2-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Methcathinone (2-Methylamino-1-phenyl-1-propanone) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Pemoline (2-amino-5-phenyl-oxazolin-4-one) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Phendimetrazine (d-3,4-dimethyl-2-phenylmorpholine) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Phenmetrazine (3-methyl-2-phenylmorpholine) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Phentermine (α,α-dimethylbenzeneethanamine) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Nalbuphine (N-cyclobutylmethyl-4,5-epoxy-morphinan-3,6,14-triol) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Propylhexedrine (1-cyclohexyl-2-methylaminopropane) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Psilocin (3-2-(dimethylamino)ethyl-4-hydroxyindole) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Psilocybin (3-2-(dimethylamino)ethyl-4-phosphoryloxyindole) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Pyrovalerone (4′-methyl-2-(1-pyrrolidinyl)valerophenone) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Pipradol (α,α-diphenyl-2-piperidinemethanol) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|... 4-Methylaminorex (4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|... 4-methyl-PCP (1-1-(4-Methylphenyl)cyclohexylpiperidine) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Zolpidem (N,N,6-trimethyl-2-(4-methylphenyl)imidazo1,2-apyridine-3-acetamide) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
5000|$|Amineptine (7-(10,11-dihydro-5H-dibenzoa,dcyclohepten-5-yl)aminoheptanoic acid) <b>and</b> any <b>salt</b> <b>thereof</b> ...|$|R
